Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARMONY trial of vaporised nicotine products versus nicotine replacement therapy for tobacco smoking in opioid agonist treatment clients
ACTRN12621000148875Phase 4Active, not recruiting
- Sponsor
- Hunter New England Local Health District
- Start
- May 2022
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Nicophar and nicotine patch in nicotine dependence (2 arms), sponsored by Hunter New England Local Health District. Primary endpoint: Self-reported 7-day point prevalence abstinence from tobacco smoking. Started May 2022; status: active, not recruiting.
02
Drugs
Nicopharnicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12621000148875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000148875.